WP_Post Object
(
[ID] => 14632
[post_author] => 6
[post_date] => 2018-06-06 09:59:00
[post_date_gmt] => 2018-06-06 08:59:00
[post_content] => The legal challenge by the homeopathic community to overturn an NHS England decision to stop funding homeopathic medicines has failed.
The judicial review, led by the British Homeopathic Association (BHA), was heard in the Royal Courts of Justice in early May. It followed a consultation by NHS bosses and subsequent decision to recommend that clinical commissioning groups (CCGs) and doctors cease funding homeopathic remedies.
BHA had argued that the consultation had a number of flaws and therefore the decision made on the basis of the consultation should be declared invalid.
Mr Justice Supperstone, while accepting that there were sufficient grounds for questions to be asked in the form of a judicial review, ruled in favour of NHS England.
The Society of Homeopaths, like all the main homeopathic bodies, supported the review and made a contribution to the costs. Principal funding has come from BHA, the Friends of Royal London Hospital for Integrated Medicine and crowd-funding.
Commenting on the ruling, Margaret Wylie, Chair of BHA, said: “The statement [by NHS England] was so prejudicial it was widely reported in the media that the decision to deny patients homeopathic medicines had already been taken. How the judge failed to recognise that this was a deliberate attempt by NHS England to unfairly influence the public is astonishing,”
She added: “It appears NHS England can fail to engage with patients properly on removing services and get away with it. That is not good enough. It is important to remember that the real losers in this case are the patients who are now being refused a treatment on which they have come to depend.”
Mark Taylor, Chief Executive of the Society of Homeopaths, added: “‘It is hugely disappointing but it was encouraging to see the homeopathic community pull together to make the case. Through 4Homeopathy, we will ensure that the campaign to promote homeopathy and enable patient choice will continue.”
[post_title] => Bid for judicial review of NHS decision fails
[post_excerpt] =>
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => bid-for-judicial-review-of-nhs-decision-fails
[to_ping] =>
[pinged] =>
[post_modified] => 2018-07-04 11:37:33
[post_modified_gmt] => 2018-07-04 10:37:33
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://homeopathy-soh.org/?p=14632
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
The legal challenge by the homeopathic community to overturn an NHS England decision to stop funding homeopathic medicines has failed.
The judicial review, led by the British Homeopathic Association (BHA), was heard in the Royal Courts of Justice in early May. It followed a consultation by NHS bosses and subsequent decision to recommend that clinical commissioning groups (CCGs) and doctors cease funding homeopathic remedies.
BHA had argued that the consultation had a number of flaws and therefore the decision made on the basis of the consultation should be declared invalid.
Mr Justice Supperstone, while accepting that there were sufficient grounds for questions to be asked in the form of a judicial review, ruled in favour of NHS England.
The Society of Homeopaths, like all the main homeopathic bodies, supported the review and made a contribution to the costs. Principal funding has come from BHA, the Friends of Royal London Hospital for Integrated Medicine and crowd-funding.
Commenting on the ruling, Margaret Wylie, Chair of BHA, said: “The statement [by NHS England] was so prejudicial it was widely reported in the media that the decision to deny patients homeopathic medicines had already been taken. How the judge failed to recognise that this was a deliberate attempt by NHS England to unfairly influence the public is astonishing,”
She added: “It appears NHS England can fail to engage with patients properly on removing services and get away with it. That is not good enough. It is important to remember that the real losers in this case are the patients who are now being refused a treatment on which they have come to depend.”
Mark Taylor, Chief Executive of the Society of Homeopaths, added: “‘It is hugely disappointing but it was encouraging to see the homeopathic community pull together to make the case. Through 4Homeopathy, we will ensure that the campaign to promote homeopathy and enable patient choice will continue.”